Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Gains from Investment Securities: 2020-2024

Historic Gains from Investment Securities for Core Scientific (CORZ) over the last 5 years, with Dec 2024 value amounting to $6.0 million.

  • Core Scientific's Gains from Investment Securities fell 476.23% to -$2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.4 million, marking a year-over-year increase of 63.58%. This contributed to the annual value of $6.0 million for FY2024, which is 65.06% up from last year.
  • Latest data reveals that Core Scientific reported Gains from Investment Securities of $6.0 million as of FY2024, which was up 65.06% from $3.7 million recorded in FY2023.
  • Core Scientific's Gains from Investment Securities' 5-year high stood at $94.0 million during FY2021, with a 5-year trough of $1.8 million in FY2020.
  • Over the past 3 years, Core Scientific's median Gains from Investment Securities value was $6.0 million (recorded in 2024), while the average stood at $13.3 million.
  • As far as peak fluctuations go, Core Scientific's Gains from Investment Securities soared by 5,031.40% in 2021, and later tumbled by 87.93% in 2023.
  • Core Scientific's Gains from Investment Securities (Yearly) stood at $1.8 million in 2020, then soared by 5,031.40% to $94.0 million in 2021, then crashed by 67.73% to $30.3 million in 2022, then crashed by 87.93% to $3.7 million in 2023, then soared by 65.06% to $6.0 million in 2024.